Related Experiment Videos
Small cell lung cancer: past, present, and future
Estelamari Rodriguez1, Rogerio C Lilenbaum
1Mount Sinai Cancer Center, Miami Beach, FL 33140, USA. erodriguez@aptiumoncology.com
Current Oncology Reports
|July 16, 2010
Summary
Small cell lung cancer (SCLC) is an aggressive cancer. This review covers current treatments like chemotherapy and radiation, and discusses emerging therapies to improve outcomes for this challenging disease.
Area of Science:
- Oncology
- Pulmonology
- Cancer Research
Background:
- Small cell lung cancer (SCLC) comprises 10-15% of all lung cancers.
- SCLC is known for rapid growth, early metastasis, and sensitivity to chemotherapy and radiation.
- Despite decreasing incidence, SCLC remains a significant health issue due to its aggressive nature and limited effective treatments.
Purpose of the Study:
- To review the historical evolution of SCLC treatment strategies.
- To outline current standard therapeutic approaches for SCLC.
- To highlight the progress and future directions in novel SCLC therapy development.
Main Methods:
- Literature review of SCLC treatment evolution.
- Summary of established SCLC therapies.
- Analysis of completed and ongoing clinical trials for SCLC.
Main Results:
- Standard treatments include platinum-based chemotherapy, thoracic radiation, and prophylactic cranial irradiation.
- Novel therapy development for SCLC has historically lagged but is advancing.
- Ongoing research is identifying promising therapeutic targets for SCLC.
Conclusions:
- SCLC treatment has evolved, with current standards including chemotherapy and radiation.
- The development of novel therapies is crucial for improving SCLC patient outcomes.
- Future research focusing on defined therapeutic targets holds promise for better SCLC management.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...